Home | September 2011News | Actos-Bladder Cancer cases are becoming prevalent, New York Attorney reports |
|
|
Actos-Bladder Cancer cases are becoming prevalent, New York Attorney reports
- Actos-Bladder Cancer cases are becoming prevalent, New York Attorney reports
- September 07, 2011
-
Actos related Bladder Cancer cases are becoming prevalent according to Rudolph F.X. Migliore, P.C. The firm has been accepting the cases since July 2011 and has seen a number of inquiries into the litigation.
The diabetes drug Actos may be linked to Bladder Cancer. While the FDA's highest warning appears on Actos for its heart attack risk, no such warning appears for Bladder Cancer. Research has shown that taking Actos for more than 1 year may increase a patient's chance for developing Bladder Cancer by up to 40%. With over 2 million people prescribed Actos, the law firm of Rudolph F.X. Migliore, P.C. has seen a number of inquiries related to Actos litigation. Actos is used to regulate the level of g...
- View more at: http://www.1888pressrelease.com/actos-bladder-cancer-cases-are-becoming-prevalent-new-york-pr-332651.html
|